TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T10670	Neuropeptide Y receptor type 2	B5T2OL	2-[[2-(4-Chlorophenyl)-2-phenylacetyl]amino]-5-(diaminomethylideneamino)-N-[(1S)-2,3-dihydro-1H-inden-1-yl]pentanamide	Investigative	44288395	C29H32ClN5O2	518	C1CC2=CC=CC=C2[C@H]1NC(=O)C(CCCN=C(N)N)NC(=O)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl	IC50 = 59000 nM	Poor binder
T10670	Neuropeptide Y receptor type 2	B75MXH	2-Diphenylacetylamino-5-guanidino-pentanoic acid 4-hydroxy-benzylamide	Investigative	21129772	C27H31N5O3	473.6	C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)O	IC50 ~ 100000 nM	Poor binder
T10670	Neuropeptide Y receptor type 2	B9ZLC4	2-Diphenylacetylamino-5-guanidino-pentanoic acid ((R)-1-phenyl-ethyl)-amide	Investigative	44287999	C28H33N5O2	471.6	C[C@H](C1=CC=CC=C1)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 177000 nM	Poor binder
T10670	Neuropeptide Y receptor type 2	BS2AT1	2-[2-(4-Chloro-phenyl)-2-phenyl-acetylamino]-5-guanidino-pentanoic acid benzylamide	Investigative	44288390	C27H30ClN5O2	492	C1=CC=C(C=C1)CNC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl	IC50 = 97000 nM	Poor binder
T10670	Neuropeptide Y receptor type 2	BT23NZ	N-[1-(7-Hydroxy-1,3,4,5-tetrahydro-2-benzazepin-2-yl)-1-oxo-5-[[N'-(3-phenylpropyl)carbamimidoyl]amino]pentan-2-yl]-2-(4-phenylphenyl)acetamide	Investigative	44287938	C39H45N5O3	631.8	C1CC2=C(CN(C1)C(=O)C(CCCNC(=NCCCC3=CC=CC=C3)N)NC(=O)CC4=CC=C(C=C4)C5=CC=CC=C5)C=CC(=C2)O	IC50 = 78000 nM	Poor binder